ArticleCancers2025

Phase II Study of Nanoliposomal Irinotecan (Nal-IRI) with 5-Fluorouracil and Leucovorin in Refractory Advanced High-Grade Neuroendocrine Cancer of Gastroenteropancreatic (GEP) or Unknown Origin.

Sarbajit Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.